En bloc resection of bladder tumour: the rebirth of past through reminiscence.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 18 05 2023
accepted: 20 07 2023
medline: 23 10 2023
pubmed: 16 8 2023
entrez: 16 8 2023
Statut: ppublish

Résumé

To learn about the history and development of en bloc resection of bladder tumour (ERBT), and to discuss its future directions in managing bladder cancer. In this narrative review, we summarised the history and early development of ERBT, previous attempts in overcoming the tumour size limitation, consolidative effort in standardising the ERBT procedure, emerging evidence in ERBT, evolving concepts in treating large bladder tumours, and the future directions of ERBT. Since the first report on ERBT in 1980, there has been tremendous advancement in terms of its technique, energy modalities and tumour retrieval methods. In 2020, the international consensus statement on ERBT has been developed and it serves as a standard reference for urologists to practise ERBT. Recently, high-quality evidence on ERBT has been emerging. Of note, the EB-StaR study showed that ERBT led to a reduction in 1-year recurrence rate from 38.1 to 28.5%. An individual patient data meta-analysis is currently underway, and it will be instrumental in defining the true value of ERBT in treating non-muscle-invasive bladder cancer. For large bladder tumours, modified approaches of ERBT should be accepted, as the quality of resection is more important than a mere removal of tumour in one piece. The global ERBT registry has been launched to study the value of ERBT in a real-world setting. ERBT is a promising surgical technique in treating bladder cancer and it has gained increasing interest globally. It is about time for us to embrace this technique in our clinical practice.

Identifiants

pubmed: 37584691
doi: 10.1007/s00345-023-04547-0
pii: 10.1007/s00345-023-04547-0
pmc: PMC10581917
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2599-2606

Informations de copyright

© 2023. The Author(s).

Références

World J Urol. 2019 Sep;37(9):1879-1887
pubmed: 30560297
J Urol. 2021 Jun;205(6):1622-1628
pubmed: 33502235
J Endourol. 2020 Mar;34(3):312-321
pubmed: 31617417
J Urol. 1997 Jun;157(6):2225-6
pubmed: 9146621
Histopathology. 2021 Jun;78(7):943-950
pubmed: 33245791
J Endourol. 2005 Jan-Feb;19(1):25-31
pubmed: 15735378
J Urol. 2023 May;209(5):882-889
pubmed: 36795962
J Urol. 2000 Mar;163(3):878-9
pubmed: 10687997
Minerva Urol Nephrol. 2021 Aug;73(4):413-416
pubmed: 34494413
J Endourol. 2006 Feb;20(2):85-91
pubmed: 16509789
Endoscopy. 2007 May;39(5):418-22
pubmed: 17516348
Eur Urol Oncol. 2022 Aug;5(4):440-448
pubmed: 35618567
World J Urol. 2010 Apr;28(2):157-61
pubmed: 20306053
World J Urol. 2011 Aug;29(4):423-7
pubmed: 21305303
J Urol. 1980 Dec;124(6):808-9
pubmed: 7192323
BJU Int. 2012 Mar;109(6):960-3
pubmed: 22360804
J Endourol. 2003 Dec;17(10):859-62
pubmed: 14744349
Eur Urol Oncol. 2023 Oct;6(5):508-515
pubmed: 37543464
Ann R Coll Surg Engl. 2010 Sep;92(6):519-24
pubmed: 20522307
Eur Urol. 2020 Oct;78(4):546-569
pubmed: 32389447
Eur Urol. 2022 Jan;81(1):75-94
pubmed: 34511303
World J Urol. 2020 Mar;38(3):703-708
pubmed: 31114949
World J Urol. 2021 Sep;39(9):3353-3358
pubmed: 33774705
World J Urol. 2015 Dec;33(12):1937-43
pubmed: 25910478
J Urol. 2001 Dec;166(6):2148-50
pubmed: 11696724
JAMA. 1983 Sep 9;250(10):1324-5
pubmed: 6348311
J Urol. 2022 Apr;207(4):754-768
pubmed: 35060770
Nat Rev Urol. 2022 May;19(5):280-294
pubmed: 35361927
J Endourol. 2014 Aug;28(8):975-9
pubmed: 24735433
J Urol. 1998 Mar;159(3):638-40
pubmed: 9474116
Eur Urol. 2017 Jun;71(6):952-960
pubmed: 28081860
Eur Urol. 2019 Feb;75(2):e27-e28
pubmed: 30262343

Auteurs

Jeremy Yuen-Chun Teoh (JY)

Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong SAR, China. jeremyteoh@surgery.cuhk.edu.hk.
Urothelial Cancer Working Group, European Association of Urology-Young Academic Urologists (EAU-YAU, Amsterdam, Netherlands. jeremyteoh@surgery.cuhk.edu.hk.

David D'Andrea (D)

Urothelial Cancer Working Group, European Association of Urology-Young Academic Urologists (EAU-YAU, Amsterdam, Netherlands.
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Andrea Gallioli (A)

Urothelial Cancer Working Group, European Association of Urology-Young Academic Urologists (EAU-YAU, Amsterdam, Netherlands.
Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain.

Takafumi Yanagisawa (T)

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

Steven MacLennan (S)

Academic Urology Unit, University of Aberdeen, Aberdeen, UK.

Rossella Nicoletti (R)

Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.
Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy.

Ng Chi Fai (NC)

Department of Surgery, S.H. Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.

Davide Maffei (D)

Department of Urology, University College London Hospital NHS Foundation Trust, London, UK.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Rodolfo Hurle (R)

Department of Urology, IRCCS Humanitas Research Hospital, Rozzano, Italy.

Lukas Lusuardi (L)

Department of Urology and Andrology, Salzburg University Hospital, Paracelsus Medical University, 5020, Salzburg, Austria.

Bernard Malavaud (B)

Institut Universitaire du Cancer Toulouse-Oncopôle, Toulouse, France.

Jun Miki (J)

Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

Mario Kramer (M)

Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany.

Hugh Mostafid (H)

Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.

Dmitry Enikeev (D)

Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.

Marek Babjuk (M)

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic.

Alberto Breda (A)

Department of Urology, Fundació Puigvert, Autonoma University of Barcelona, Barcelona, Spain.

Shahrokh Shariat (S)

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Department of Urology, 2nd Faculty of Medicine, Hospital Motol, Charles University, Prague, Czech Republic.
Department of Urology, Weill Cornell Medical College, New York, NY, USA.
Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.

Paolo Gontero (P)

Department of Urology, Città Della Salute e Della Scienza, University of Torino School of Medicine, Turin, Italy.

Thomas Herrmann (T)

Department of Urology, Kantonsspital Frauenfeld, Frauenfeld, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH